Marc Rubin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Marc Rubin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Marc Rubin. Marc Rubin is Director in MEDAREX INC ($MEDX) and Executive Chairman in TITAN PHARMACEUTICALS INC ($TTNP) and Director in CURIS INC ($CRIS) and Director in GALECTIN THERAPEUTICS INC ($GALT).
Latest Insider Trading Transactions of Marc Rubin
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRIS, GALT, MEDX, TTNP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 2.11 | 70,000 | 147,700 | 70,000 | |
| Mar 29 2021 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 2.11 | 40,000 | 84,400 | 40,000 | |
| Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 4.02 | 150,000 | 603,000 | 150,000 | |
| Mar 04 2020 | CRIS | CURIS INC | Rubin Marc | Director | Option Exercise | A | 1.26 | 180,000 | 226,800 | 180,000 | |
| Jan 13 2020 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 2.86 | 30,000 | 85,800 | 30,000 | |
| Apr 03 2019 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 1.75 | 200,000 | 350,000 | 200,000 | |
| Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | M | 2.39 | 859 | 2,053 | 33,065 | |
| Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | M | 2.39 | 43,326 | 103,549 | 33,924 | |
| Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Sell | S | 6.02 | 859 | 5,175 | 13,581 | 14.4 K to 13.6 K (-5.95 %) |
| Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | M | 2.39 | 859 | 2,053 | 14,440 | 13.6 K to 14.4 K (+6.33 %) |
| Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Sell | S | 6.02 | 43,326 | 261,026 | 13,581 | 56.9 K to 13.6 K (-76.13 %) |
| Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | M | 2.39 | 43,326 | 103,549 | 56,907 | 13.6 K to 56.9 K (+319.02 %) |
| Feb 25 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Sell | S | 6.00 | 7,000 | 42,000 | 13,581 | 20.6 K to 13.6 K (-34.01 %) |
| Jan 25 2019 | CRIS | CURIS INC | Rubin Marc | Director | Sell | S | 1.05 | 18,500 | 19,477 | 28,819 | 47.3 K to 28.8 K (-39.10 %) |
| Jan 23 2019 | CRIS | CURIS INC | Rubin Marc | Director | Option Exercise | A | 1.16 | 180,000 | 208,800 | 180,000 | |
| Jan 23 2019 | CRIS | CURIS INC | Rubin Marc | Director | Option Exercise | A | 1.16 | 180,000 | 208,800 | 180,000 | |
| Jan 18 2019 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 4.72 | 25,000 | 118,000 | 25,000 | |
| Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 0.25 | 400,000 | 100,000 | 400,000 | |
| Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 0.25 | 400,000 | 100,000 | 556,317 | 156.3 K to 556.3 K (+255.89 %) |
| Sep 06 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | M | 0.89 | 6,000 | 5,340 | 16,500 | |
| Sep 06 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Sell | S | 6.58 | 11,900 | 78,256 | 20,581 | 32.5 K to 20.6 K (-36.64 %) |
| Sep 06 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | M | 0.00 | 6,000 | 0 | 32,481 | 26.5 K to 32.5 K (+22.66 %) |
| Sep 04 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | M | 0.89 | 29,000 | 25,810 | 22,500 | |
| Sep 04 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Sell | S | 6.08 | 58,100 | 353,312 | 26,481 | 84.6 K to 26.5 K (-68.69 %) |
| Sep 04 2018 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | M | 0.00 | 29,000 | 0 | 84,581 | 55.6 K to 84.6 K (+52.18 %) |
| Mar 09 2018 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 0.97 | 170,000 | 164,900 | 170,000 | |
| Jan 24 2018 | CRIS | CURIS INC | Rubin Marc | Director | Grant | A | 0.00 | 185,000 | 0 | 236,596 | 51.6 K to 236.6 K (+358.55 %) |
| Dec 18 2017 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 2.39 | 77,250 | 184,628 | 77,250 | |
| Dec 08 2017 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Buy | P | 1.85 | 7,000 | 12,972 | 55,581 | 48.6 K to 55.6 K (+14.41 %) |
| Nov 16 2017 | CRIS | CURIS INC | Rubin Marc | Director | Buy | P | 0.98 | 25,000 | 24,500 | 51,596 | 26.6 K to 51.6 K (+94.00 %) |
| Mar 02 2017 | CRIS | CURIS INC | Rubin Marc | Director | Option Exercise | A | 2.31 | 120,000 | 277,200 | 120,000 | |
| Feb 14 2017 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 3.90 | 70,000 | 273,000 | 70,000 | |
| Dec 19 2016 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | A | 0.89 | 51,500 | 45,835 | 51,500 | |
| Feb 02 2016 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 5.10 | 79,100 | 403,410 | 79,100 | |
| Jan 21 2016 | CRIS | CURIS INC | Rubin Marc | Director | Option Exercise | A | 1.76 | 50,000 | 88,000 | 50,000 | |
| Jan 11 2016 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 3.25 | 5,000 | 16,250 | 156,317 | 151.3 K to 156.3 K (+3.30 %) |
| Dec 16 2015 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 5.10 | 170,000 | 867,000 | 170,000 | |
| Aug 31 2015 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 0.72 | 50,000 | 35,750 | 832,200 | 782.2 K to 832.2 K (+6.39 %) |
| Jul 08 2015 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | D | 3.59 | 16,714 | 60,003 | 0 | |
| Jul 08 2015 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Option Exercise | D | 5.82 | 16,495 | 96,001 | 0 | |
| Jul 08 2015 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Grant | A | 0.00 | 2,768 | 0 | 48,581 | 45.8 K to 48.6 K (+6.04 %) |
| Jul 08 2015 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Grant | A | 0.00 | 28,367 | 0 | 45,813 | 17.4 K to 45.8 K (+162.60 %) |
| Jul 08 2015 | GALT | GALECTIN THERAPEUT ... | Rubin Marc | Director | Grant | A | 0.00 | 11,112 | 0 | 17,446 | 6.3 K to 17.4 K (+175.43 %) |
| Mar 18 2015 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 0.60 | 200,000 | 120,000 | 200,000 | |
| Sep 03 2009 | MEDX | MEDAREX INC | Rubin Marc | Director | Option Exercise | D | 0.00 | 6,721 | 0 | 0 | |
| Sep 03 2009 | MEDX | MEDAREX INC | Rubin Marc | Director | Option Exercise | D | 0.00 | 3,161 | 0 | 0 | |
| Sep 03 2009 | MEDX | MEDAREX INC | Rubin Marc | Director | Option Exercise | D | 3.72 | 18,000 | 66,960 | 0 | |
| Sep 03 2009 | MEDX | MEDAREX INC | Rubin Marc | Director | Option Exercise | D | 7.91 | 18,000 | 142,380 | 0 | |
| Sep 03 2009 | MEDX | MEDAREX INC | Rubin Marc | Director | Option Exercise | D | 12.57 | 30,000 | 377,100 | 0 | |
| Mar 09 2009 | MEDX | MEDAREX INC | Rubin Marc | Director | Option Exercise | A | 0.00 | 6,721 | 0 | 6,721 | |
| Mar 09 2009 | MEDX | MEDAREX INC | Rubin Marc | Director | Option Exercise | A | 3.72 | 18,000 | 66,960 | 18,000 | |
| May 19 2008 | MEDX | MEDAREX INC | Rubin Marc | Director | Option Exercise | A | 0.00 | 3,161 | 0 | 3,161 | |
| May 19 2008 | MEDX | MEDAREX INC | Rubin Marc | Director | Option Exercise | A | 7.91 | 18,000 | 142,380 | 18,000 | |
| Dec 04 2007 | MEDX | MEDAREX INC | Rubin Marc | Director | Option Exercise | A | 12.57 | 30,000 | 376,950 | 30,000 |
Page: 1